Literature DB >> 870520

Adrenergic modulation of growth hormone secretion in acromegaly: alpha- and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppresion.

P E Cryer, W H Daughaday.   

Abstract

The serum GH response to oral L-Dopa during the separate infusions of saline, phentolamine and propranolol was exmined in 12 acromegalic patients. In six L-Dopa responsive patients, serum GH concentrations rose during propranolol infusions (and fell during phentolamine infusions as previously reported). There was no effect of propranolol or phentolamine on the fall in serum GH following oral L-Dopa in this group of patients. Thus, beta-adrenergic, as well as alpha-adrenergic, mechanisms are involved to the regulation of GH secretion in a qualitatively normal fashion in some acromegalic patients. However, the qualitatively abnormal suppressive effect of L-Dopa on GH secretion seen in some acromegalic patients does not appear to be mediated through either alpha-adrenergic or beta-adrenergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870520     DOI: 10.1210/jcem-44-5-977

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

2.  Pituitary function and growth hormone dynamics in acromegaloidism.

Authors:  R B Mims
Journal:  J Natl Med Assoc       Date:  1978-12       Impact factor: 1.798

Review 3.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

4.  The effects of oral clonidine on the growth hormone level in acromegalic patients.

Authors:  L Gáspár; T Janáky; Z Valkusz; F A László
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

5.  Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly.

Authors:  J Feely
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.